CIK 0001819576 · Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851710962
- Phone
- 919.328.4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $23,494,367
- in 17 filings, $12.2M under 10b5-1 plans
Net −$23,494,367. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-26 | Boyle Dana Chief Accounting Officer | Sale 10b5-1 | −1,581 | $43.19 | $68K | 164,028 |
| 2026-10-26 | Adair Jason Chief Business Officer | Sale 10b5-1 | −688 | $43.19 | $30K | 177,269 |
| 2026-10-12 | Schundler Russell General Counsel | Sale 10b5-1 | −13,692 | $28.48 | $390K | 602,841 |
| 2026-10-12 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −9,218 | $28.48 | $263K | 126,368 |
| 2026-10-12 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −8,863 | $28.48 | $252K | 181,487 |
| 2026-10-12 | Krepp Sarah Chief Human Resource Officer | Sale 10b5-1 | −5,245 | $28.48 | $149K | 115,241 |
| 2026-10-12 | Khindri Sanjeev Chief Development Officer | Sale 10b5-1 | −1,101 | $28.48 | $31K | 64,846 |
| 2026-10-12 | Kaseta Michael CFO and COO | Sale 10b5-1 | −18,938 | $28.48 | $539K | 340,148 |
| 2026-10-12 | JEFFS ROGER Chief Executive Officer | Sale 10b5-1 | −32,744 | $28.48 | $933K | 1,125,848 |
| 2026-10-12 | Boyle Dana Chief Accounting Officer | Sale 10b5-1 | −5,892 | $28.48 | $168K | 165,609 |
| 2026-10-12 | Adair Jason Chief Business Officer | Sale 10b5-1 | −7,301 | $28.48 | $208K | 177,957 |
| 2026-10-09 | Schundler Russell General Counsel | Option exercise 10b5-1 | +3,758 | 610,124 | ||
| 2026-10-09 | Schundler Russell General Counsel | Option exercise 10b5-1 | +6,409 | 616,533 | ||
| 2026-10-09 | Schundler Russell General Counsel | Option exercise · Performance Stock Units 10b5-1 | −3,758 | 18,792 | ||
| 2026-10-09 | Schundler Russell General Counsel | Option exercise · Performance Stock Units 10b5-1 | −6,409 | 57,680 | ||
| 2026-10-09 | Saggar Rajeev Chief Medical Officer | Option exercise 10b5-1 | +3,530 | 131,100 | ||
| 2026-10-09 | Saggar Rajeev Chief Medical Officer | Option exercise 10b5-1 | +4,486 | 135,586 | ||
| 2026-10-09 | Saggar Rajeev Chief Medical Officer | Option exercise · Performance Stock Units 10b5-1 | −3,530 | 17,654 | ||
| 2026-10-09 | Saggar Rajeev Chief Medical Officer | Option exercise · Performance Stock Units 10b5-1 | −4,486 | 40,376 | ||
| 2026-10-09 | Moomaw Scott Chief Commercial Officer | Option exercise 10b5-1 | +3,108 | 185,992 |
Page 1 of 18 · 344 trades